| MANAGER | Mettle Capital, founded by Ashish Agrawal, Ishaan Mittal and Tejeshwi Sharma, all former Peak XV managing directors |
|---|
| FUND | Mettle Capital Fund I · target US$350–400m (about ₹3,380–3,860 Cr at ₹96.5) · first close was reported as planned within a quarter of launch; no confirmation found |
| STRATEGY | Seed to Series B · enterprise AI, deeptech and consumer internet |
| DEBUT DEAL | Co-investment with Peak XV in Empirical Machines, an AI-for-science start-up (16 Oct 2026; round reported at about US$20m) |
| NOT CONFIRMED | Amount raised, LP list, cheque sizes, fees |
| THE ACCESS POINT
Mettle Capital Fund I is raising; one outlet reported the US$350m figure as already raised, but this was described as unconfirmed. AIF commitments start at ₹1 crore. |
|---|
Executive decision summary
| THE BOTTOM LINE | Mettle Capital is a venture spinout. Three former Peak XV managing directors, Ashish Agrawal, Ishaan Mittal and Tejeshwi Sharma, launched it in 2026 with a debut fund targeting US$350–400 million and a mandate that runs from seed to Series B across enterprise AI, deeptech and consumer internet. Its first announced investment was a co-investment with Peak XV in Empirical Machines, an AI-for-science start-up, in October 2026. The pedigree is strong; the firm itself has no track record, and no confirmed close or LP list has been published. One outlet reported US$350 million as raised, citing another publication, but flagged that it was not confirmed. The target would make Mettle one of the larger debut funds in India. |
|---|
| WHICH INVESTOR | Mettle fits a watch-list IF you want a new India fund from experienced partners with a stated AI and deeptech tilt.
Wait IF you need a confirmed close, LP names or the first portfolio. |
| COMFORT FIT | Mettle = senior chefs opening their own restaurant. Known skills, new kitchen.
Co-investing with Peak XV = the old employer as the first customer. A positive signal and a continuing tie.
$350–400m debut = a big first-time fund. Funds this size are usually raised on the founders' track records, not the firm's.
Activate and F2A (Reports 39 and 26) = AI-focused peers at different stages. |
| THE RUPEIA NUMBER | 3 of 3. All three founders are former Peak XV managing directors, so the firm's credibility rests on the founders' prior record at a larger platform, not on Mettle's own. |
1 CLAIM REGISTER: EVIDENCE GRADING
| Claim | Source | Grade | Rupeia assessment |
|---|
| Founders: Ashish Agrawal, Ishaan Mittal, Tejeshwi Sharma (ex-Peak XV MDs) | Inc42; Venture Intelligence; Indian Startup Times | C | Established |
| Target US$350–400m for Mettle Capital Fund I | Inc42; Dealroom; Pulse | C | Stated target |
| Seed to Series B; enterprise AI, deeptech, consumer internet | Press reports | C | Stated |
| First deal: Empirical Machines co-investment with Peak XV, 16 Oct 2026 | NewsBytes; Emergent | C | Reported |
| US$350m raised | Value Add VC citing another outlet | D | Unconfirmed |
2 STRATEGY, FUND SIZE AND PEERS
| Measure (Rupeia calculation, ₹96.5 per US$) | Value |
|---|
| Target in rupees | ₹3,380–3,860 Cr |
| If 25 companies across seed to Series B | ~₹135–155 Cr per company in total |
| Versus Inflexor Fund III target (Report 13) | 2.7–3.1x larger (₹1,250 Cr) |
| Versus Sparrow Fund III (Report 34) | 7–8x larger (₹475 Cr) |
Peak XV, the founders' former firm, raised a fund reported at US$1.3 billion with a smaller size and AI focus (Whalesbook). Mettle's first deal, Empirical Machines, is an AI-for-science start-up that raised about US$20 million, with Mettle joining Peak XV in the round.
| RUPEIA READ
A seed-to-Series-B range with a US$350–400 million fund requires a mix: small early cheques and large Series B cheques. The strategy is credible only if the founders can win competitive late-seed and Series A rounds, where established funds hold advantages. Their prior relationship with Peak XV helps with co-investment but also invites comparison. |
|---|
3 WHAT A US$350–400M FUND NEEDS TO RETURN
Illustrative maths, using assumed terms (15% fees over life, 20% carry above paid-in capital) because Mettle has not published its terms.
| Step | US$350m fund | US$400m fund |
|---|
| Invested capital (85%) | ~US$298m | ~US$340m |
| Net 3x to investors | US$1,050m | US$1,200m |
| Gross proceeds required (G − 0.2 × (G − paid-in) = net) | ~US$1,225m | ~US$1,400m |
| Gross multiple on invested capital | ~4.1x | ~4.1x |
| RUPEIA READ
A 3x net result needs a gross multiple above 4x on a fund of this size, which means several portfolio companies reaching US$1 billion-plus outcomes. A seed-to-Series-B mandate gives Mettle early entry prices for that, but also long holding periods. |
|---|
4 PEDIGREE AGAINST RECORD
| Known | Unknown |
|---|
| Three founders are former Peak XV managing directors | Which Peak XV investments each led, and their individual returns |
| Target US$350–400m (about ₹3,380–3,860 Cr) | Amount raised; LP names; fees |
| Debut deal: co-investment with Peak XV in Empirical Machines (round about US$20m) | Mettle's own cheque size |
| Mandate: seed to Series B in enterprise AI, deeptech, consumer internet | Split by stage |
| RUPEIA CALCULATION
Peak XV, the founders' former firm, reportedly raised about US$1.3 billion in its latest fund. Mettle's target is 27–31% of that, so the new firm is a mid-sized fund by comparison, but 2.7–3.1 times the size of Inflexor's ₹1,250 crore Fund III (Report 13). |
|---|
5 THE DEBUT DEAL: EMPIRICAL MACHINES
| Item | Published detail (NewsBytes, Oct 2026) |
|---|
| Company | Empirical Machines, an AI-for-science start-up; uses AI to speed up scientific discovery, especially in chemistry |
| Founder | Former OpenAI researcher Shyamal Hitesh Anadkat |
| Round | About US$20m with Mettle Capital and Peak XV co-investing; valuation reported at US$80m |
| Wording | Described as "set to co-invest"; no company announcement was found |
| RUPEIA CALCULATION
At a US$80m valuation, a US$20m round is 25% of the company. Mettle's own share of the round is not published; if it took one-third of the round, that would be about US$6.7m, or under 2% of a US$350m fund (illustration only). |
|---|
| RUPEIA READ
An AI-for-science start-up is a global, research-led bet rather than an Indian consumer play, which suggests Mettle's deeptech label is real. The fact that the first deal is alongside Peak XV also shows how closely the new firm is tied to its founders' former home. |
|---|
6 KEY TERMS USED IN THIS REPORT
The terms below are used throughout this report. The first table gives the general meaning; the second shows what each term refers to in this transaction.
| Term | Meaning |
|---|
| First close | The date a fund first accepts investor money and may start investing; later closes add more investors until the final close. |
| Final close | The last date investors can join; the fund's size is fixed from here. |
| Greenshoe | An agreed amount above the base target that the manager may accept if demand is strong. |
| DPI | Distributions to paid-in capital: cash returned divided by cash invested. 1.0x means investors have their money back. |
| IRR | Annualised return that accounts for when cash went in and came out. Gross is before fees and carry; net is after. |
| Category I and II AIF | SEBI classes for alternative investment funds. Minimum commitment is ₹1 crore per investor. |
| Term in this report | What it refers to here |
|---|
| Spinout | Three ex-Peak XV managing directors |
| Target | US$350–400m |
| Co-investment | Debut deal alongside Peak XV |
| Series B | Upper end of the mandate |
7 RISKS, SCENARIOS AND FINAL VIEW
| Risk | Evidence | Severity | Kill condition |
|---|
| No firm track record | New firm, first fund | HIGH | Early deals fail to attract follow-ons |
| Fundraising | Close not confirmed | MEDIUM | Final close well below US$350m |
| Broad mandate | Seed to Series B; AI, deeptech, consumer | MEDIUM | Lack of edge |
| Dependence on prior platform | Debut deal alongside Peak XV | LOW | Deal flow tied to old network |
| AI valuation risk | AI rounds priced high | MEDIUM | Valuation reset |
| Scenario | What happens | Outcome |
|---|
| Bull | US$400m closes; early winners in AI | Becomes a top India fund |
| Base | Close at US$250–350m; steady deployment | Solid first fund |
| Bear | Fundraising slows; deal competition | Smaller fund; weak returns |
Mettle has the strongest asset a new fund can have, experienced founders, and the usual liability, no record of its own. Rupeia's view: wait for a confirmed close, the LP list and a few more disclosed investments before judging the strategy.
Frequently asked questions
What is Mettle Capital?
A venture firm launched in 2026 by Ashish Agrawal, Ishaan Mittal and Tejeshwi Sharma, all former Peak XV managing directors, targeting US$350–400 million for its first fund.
What will Mettle invest in?
Seed to Series B companies in enterprise AI, deeptech and consumer internet in India.
What was Mettle's first investment?
A co-investment with Peak XV in Empirical Machines, an AI-for-science start-up, announced on 16 October 2026; the round was reported at about US$20 million.
Has Mettle closed its fund?
No close has been confirmed. One outlet reported US$350 million as raised but noted that this was not confirmed.
Who are the founders?
Ashish Agrawal, Ishaan Mittal and Tejeshwi Sharma.
Source log
Inc42: Ex-Peak XV MDs launch Mettle Capital, target US$350–400 Mn fund
Venture Intelligence: 3 ex-Peak XV Partners execs set up Mettle Capital; target US$400m corpus
Indian Startup Times: Former Peak XV executives launch Mettle Capital
StartupTalky: Ex-Peak XV trio launches Mettle Capital with US$350–400 million fund
NewsBytes: Mettle Capital reunites founding partners, joins US$20 million Empirical Machines round
Value Add VC: Mettle Capital launches with US$350M India fund
Whalesbook: Peak XV raises US$1.3B fund, smaller size, AI focus
| DISCLAIMER
This document is published strictly for informational, educational and academic record-keeping purposes. The publisher is not a SEBI Registered Investment Adviser (RIA) or Research Analyst (RA). It does not constitute personal investment advice, a financial recommendation, or an offer or solicitation to buy, sell or subscribe to any securities. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. |
|---|